The Use of Alternative Medicine by Palliative Care Patients
NCT ID: NCT03260946
Last Updated: 2018-09-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
120 participants
OBSERVATIONAL
2017-07-11
2018-05-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
These aims will be achieved through the following objectives:
1. Describe the prevalence of Complementary and Alternative Medicine practitioner and product use in the outpatient population of palliative care centres in Lyon, France
2. Describe the characteristics of Complementary and Alternative Medicine users the outpatient population of palliative care centres in Lyon, France
3. Estimate the Complementary and Alternative Medicine expenditure of the outpatient population of palliative care centres in Lyon, France
4. Describe the rates of disclosure of both Complementary and Alternative Medicine and conventional health care to health professionals by the outpatient population of palliative care centres in Lyon, France
5. Describe the reasons for disclosure or non-disclosure of both Complementary and Alternative Medicine and conventional health care to health professionals by the outpatient population of palliative care centres in Lyon, France
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Advance Care Planning in Palliative Care
NCT05662917
Prospective Study of the Perception of Palliative Care by Relatives of Patients Treated in Oncology
NCT01936428
Elaboration of a Multi-dimensional Indicator of Quality in Palliative Care
NCT02814682
Assessment of the Reasons for Accepting or Refusing Early Palliative Care
NCT04717440
Needs Assessment of Cancer Patients With Complementary and Alternative Medicines
NCT03954509
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Palliative/Supportive care
Individuals with cancer receiving palliative or supportive care
Complementary medicine use
The prevalence of complementary medicine use
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Complementary medicine use
The prevalence of complementary medicine use
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Can read and understand French
3. Has been diagnosed with cancer
Exclusion Criteria
2. They are not able to read and understand French
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
USP de Charmettes - Croix rouge française
Lyon, , France
Service E.M.S.P. Groupement Hospitalier Nord - Hôpital de la Croix-Rousse
Lyon, , France
Centre de Soins Palliatifs Lyon-Sud Pavillon 1K - Centre Hospitalier Lyon-Sud
Pierre-Bénite, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69HCL17_0217
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.